Avivia is a Dutch independent pharmaceutical R&D organization and your partner in drug (re)formulation, repurposing and repositioning. Our expertise and capabilities are centered around the development of value-added generic drugs, life cycle management of branded drug products, and complex formulation and CMC development of new drug products (NCE). We operate a hybrid business model combining specialized pharmaceutical Avivia for all Big Pharma, speciality pharma, small entrepreneurial drug development firms, generic drug companies, universities, excipient manufacturers, and even venture capital firms… our customer base is very broad and diverse. IP creation and evasion Be it the creation of new formulation patents for originator products or the evasion of established formulation patents for generic drug development, we are constantly seeking new IP opportunities to maximize product value. Avivia to kick-start a development or to get you back on track We like to get involved right from the start of a development project, but also when the development has derailed or – in the worst case and despite all previous efforts – has reached a dead end. We are known for our ability to transform the idea into a product, or to see through the results and bring up a new approach leading to commercial success. Network to accelerate Avivia has access to a great team of pharmaceutical development professionals as well as to state-of-the-art laboratory infrastructure and equipment. We have also developed a large network or preferred partners in other fields such as pre-clinical development, GMP manufacturing and regulatory affairs. Excipia. Excipia is our excipient knowledge platform focused on excipient related troubleshooting, characterization and reversed engineering, see our dedicated website https://www.excipia.eu. f you are interested to learn more about Avivia, don’t hesitate to contact us and we would be happy to help you accelerating your development programs!